Hyaluronic acid in tobacco-exposed rats. Inflammatory reaction, and duration of effects
Carregando...
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ACTA CIRURGICA BRASILEIRA
Citação
ACTA CIRURGICA BRASILEIRA, v.34, n.2, article ID UNSP e201900202, 7p, 2019
Resumo
Purpose: To evaluate the hyaluronic acid (HA) inflammatory reaction, fibroblasts, fibrosis and duration of effect in the dorsal region of tobacco-exposed rats. Methods: Ten Wistar rats were divided into two groups: tobacco-exposed-group (TEG;n=5) and air-control-group (CG;n=5). The TEG animals were tobacco-exposed twice a day, 30-minutes/session, during 60 days. After this period, all animals received 0.1 mL HA subcutaneous injection in the dorsal area. The volume of HA was measured immediately after HA injection and weekly using a hand-caliper in nine weeks. After this period, all the animals were euthanized, and a specimen of was collected to evaluate inflammatory cells, fibroblasts, and fibrosis by HE. Results: This study showed a higher inflammatory reaction in TEG than CG: inflammatory cell-count (CG: 1.07 +/- 0.9; TEG: 8.61 +/- 0.36, p<0.001); fibroblast count (CG: 2.92 +/- 0.17; TEG: 19.14 +/- 0.62, p<0.001), and fibrosis quantification (CG: 2.0; TEG: 3.75, p<0.001). The analysis of the HA volume in nine weeks in the dorsal region did not show a difference between groups (p=0.39). Conclusions: This study suggested that the HA injection in the TEG caused an increase in inflammatory cell count, fibroblast, and fibrosis quantification when compared to the CG. There was no difference in the duration of effect of HA between the groups.
Palavras-chave
Tobacco, Hyaluronic Acid, Rats
Referências
- Basta SL, 2015, FACIAL PLAST SURG CL, V23, P417, DOI 10.1016/j.fsc.2015.07.001
- Billon R, 2017, ANN CHIR PLAST ESTH, V62, P261, DOI 10.1016/j.anplas.2016.12.002
- Biselli PJC, 2011, BRAZ J MED BIOL RES, V44, P460, DOI 10.1590/S0100-879X2011007500040
- Camargo CP, 2016, ACTA CIR BRAS, V31, P720, DOI [10.1590/S0102-865020160110000003, 10.1590/s0102-865020160110000003]
- Camargo CP, 2015, ACTA CIR BRAS, V30, P639, DOI 10.1590/S0102-865020150090000009
- Carruthers Jean, 2006, J Drugs Dermatol, V5, P959
- Costa CR, 2016, PLAST RECONSTR SURG, V138, p233E, DOI 10.1097/PRS.0000000000002008
- Da Luz P, 2018, ENDOTHELIUM CARDIOVA
- Frohlich M, 2003, EUR HEART J, V24, P1365, DOI 10.1016/S0195-668X(03)00260-4
- Gentry-Nielsen MJ, 2004, ALCOHOL CLIN EXP RES, V28, P1120, DOI 10.1097/01.ALC.0000136383.45378.91
- Hillel AT, 2012, DERMATOL SURG, V38, P471, DOI 10.1111/j.1524-4725.2011.02273.x
- KANNEL WB, 1987, AM HEART J, V113, P1006, DOI 10.1016/0002-8703(87)90063-9
- Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020
- Monheit GD, 2006, DERMATOL THER, V19, P141, DOI 10.1111/j.1529-8019.2006.00068.x
- Nowacki M, 2014, AESTHET SURG J, V34, P1261, DOI 10.1177/1090820X14548212
- Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X
- Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183
- World Health Organization, WHO GLOB REP TRENDS